MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Mon, Feb 2, 2026
Feb 2
sold $134.16k of ALKS
4,000 shares @ $33.54
Decreased holdings by -6.50%
46th largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 18% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.76%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback